0000950170-24-024225.txt : 20240301
0000950170-24-024225.hdr.sgml : 20240301
20240301195429
ACCESSION NUMBER: 0000950170-24-024225
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COVA CHARLES J
CENTRAL INDEX KEY: 0001994357
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15925
FILM NUMBER: 24712434
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC
CENTRAL INDEX KEY: 0001108109
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 133893191
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615-465-7000
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
FORMER COMPANY:
FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/
DATE OF NAME CHANGE: 20000229
4
1
ownership.xml
4
X0508
4
2024-03-01
0001108109
COMMUNITY HEALTH SYSTEMS INC
CYH
0001994357
COVA CHARLES J
4000 MERIDIAN BOULEVARD
FRANKLIN
TN
37067
false
true
false
false
Regional President
false
Common Stock
2024-03-01
4
A
false
25000
0
A
58701
D
Performance Based Restricted
0
2024-03-01
4
A
false
50000
0
A
Common Stock
50000
50000
D
Stock Options (Right to Buy)
2.87
2024-03-01
4
A
false
25000
0
A
2025-03-01
2034-02-28
Common Stock
25000
50000
D
The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
Christopher G. Cobb, Attorney in Fact for Charles J. Cova
2024-03-01